Business Context and Reporting Period
Aimei Health Technology Co., Ltd. (AFJK), a Cayman Islands emerging growth company, filed this Form 8-K on January 5, 2026. The filing reports the extension of the company's deadline to consummate an initial business combination.
Key Financial Metrics
- Extension Payment: $34,330.96 deposited into the trust account.
- Promissory Note Issued: $34,330.96 principal amount.
- Debt Terms: Unsecured, non-interest bearing.
- Liquidity Impact: Funds added to the trust account to maintain the extension.
Material Changes
The company extended its termination date from January 6, 2026, to February 6, 2026. This represents the fourteenth extension permitted under the company's Amended and Restated Articles of Association. The extension was funded by the issuance of a promissory note to the Sponsor (Aimei Health Ltd) and United Hydrogen Group Inc., with each party contributing $17,165.48.
Outlook, Risks, and Unusual Items
The promissory note becomes due and payable upon the consummation of the business combination with United Hydrogen. The payees have the option, but not the obligation, to convert the note into private units at $10.00 per unit (one ordinary share and one right) prior to closing. The filing does not provide specific guidance on the likelihood of the business combination closing or other operational risks beyond the extension mechanics.
Investor Verification Checklist
- Verify the total number of outstanding public shares to confirm the $0.033 per share extension calculation.
- Confirm the status of the proposed business combination with United Hydrogen Group Inc.
- Review the full text of the Promissory Note (Exhibit 10.1) for conversion mechanics and default provisions.
- Check if the company has reached the maximum number of extensions allowed under its charter.